Franz Buchegger

4.0k total citations
85 papers, 3.1k citations indexed

About

Franz Buchegger is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Franz Buchegger has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Franz Buchegger's work include Radiopharmaceutical Chemistry and Applications (42 papers), Monoclonal and Polyclonal Antibodies Research (31 papers) and Medical Imaging Techniques and Applications (14 papers). Franz Buchegger is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (42 papers), Monoclonal and Polyclonal Antibodies Research (31 papers) and Medical Imaging Techniques and Applications (14 papers). Franz Buchegger collaborates with scholars based in Switzerland, United States and France. Franz Buchegger's co-authors include Robert Gurny, Éric Allémann, Jean‐Pierre Mach, Magali Schreyer, Angelika Bischof Delaloye, S Carrel, Y.M. Dupertuis, Raymond Miralbell, André Pèlegrin and Habib Zaidi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.

In The Last Decade

Franz Buchegger

85 papers receiving 3.0k citations

Peers

Franz Buchegger
Chang H. Paik United States
Gamal Akabani United States
Jiyun Shi China
Reinier Hernandez United States
F. Buchegger Switzerland
Gabriela Krämer-Marek United Kingdom
Chang H. Paik United States
Franz Buchegger
Citations per year, relative to Franz Buchegger Franz Buchegger (= 1×) peers Chang H. Paik

Countries citing papers authored by Franz Buchegger

Since Specialization
Citations

This map shows the geographic impact of Franz Buchegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Buchegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Buchegger more than expected).

Fields of papers citing papers by Franz Buchegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Buchegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Buchegger. The network helps show where Franz Buchegger may publish in the future.

Co-authorship network of co-authors of Franz Buchegger

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Buchegger. A scholar is included among the top collaborators of Franz Buchegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Buchegger. Franz Buchegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mainta, Ismini, Thomas Zilli, Jean‐Christophe Tille, et al.. (2018). The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An 18F-MISO PET-MRI Study. International Journal of Radiation Oncology*Biology*Physics. 102(4). 1210–1218. 10 indexed citations
2.
Viertl, David, Philippe Morel, Léo H. Bühler, et al.. (2015). [b]CERN-MEDICIS[/b] : une nouvelle infrastructure pour la production de radioisotopes à usage médical. Revue Médicale Suisse. 11(479). 1340–1344. 1 indexed citations
4.
Boubaker, Ariane, John O. Prior, Jean‐Pierre Willi, et al.. (2012). Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide. European Journal of Nuclear Medicine and Molecular Imaging. 39(12). 1868–1875. 5 indexed citations
5.
Park, Steven, Donald K. Hamlin, Yukang Lin, et al.. (2011). Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma. Clinical Cancer Research. 17(23). 7373–7382. 27 indexed citations
6.
Loisel, Séverine, Josée Golay, Franz Buchegger, et al.. (2011). Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia. Molecular Cancer. 10(1). 42–42. 19 indexed citations
7.
Weber, Damien C., Thomas Zilli, Franz Buchegger, et al.. (2008). [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma. Radiation Oncology. 3(1). 44–44. 86 indexed citations
8.
Delaloye, Angelika Bischof, et al.. (2006). Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine. European Journal of Nuclear Medicine and Molecular Imaging. 33(5). 613–620. 8 indexed citations
9.
Buchegger, Franz, et al.. (2006). Auger radiation targeted into DNA: a therapy perspective. European Journal of Nuclear Medicine and Molecular Imaging. 33(11). 1352–1363. 145 indexed citations
10.
Albrecht, Susanne, Franz Buchegger, Dmitry Soloviev, et al.. (2006). 11C-acetate PET in the early evaluation of prostate cancer recurrence. European Journal of Nuclear Medicine and Molecular Imaging. 34(2). 185–196. 104 indexed citations
11.
Buchegger, Franz, et al.. (2005). Biodegradable Nanoparticles for Direct or Two-Step Tumor Immunotargeting. Bioconjugate Chemistry. 17(1). 139–145. 112 indexed citations
13.
Buchegger, Franz, et al.. (2003). Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine. European Journal of Nuclear Medicine and Molecular Imaging. 30(2). 239–246. 9 indexed citations
14.
Buchegger, Franz, et al.. (2001). Fractionated Irradiation Combined with Carbogen Breathing and Nicotinamide of Two Human Glioblastomas Grafted in Nude Mice. Radiation Research. 155(1). 26–31. 7 indexed citations
15.
Pèlegrin, André, Françoise Xavier, Jacques Barbet, et al.. (2000). Immunociblage des tumeurs : situation et perspectives en 2000. Bulletin du Cancer. 87(11). 1 indexed citations
16.
Bhardwaj, Ranjit, et al.. (1993). Carcinoembryonic Antigen and Related Glycoproteins in Psoriasis. Pathobiology. 61(1). 19–24. 6 indexed citations
17.
Mach, Jean‐Pierre, André Pèlegrin, & Franz Buchegger. (1991). Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Current Opinion in Immunology. 3(5). 685–693. 44 indexed citations
18.
Ryser, Jean‐Etienne, S Carrel, Franz Buchegger, & A Donath. (1990). Immunoscintigraphy with biosynthetically-labeled 75Se-antibodies—II. Comparison with antibodies labeled by radioiodination. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(5). 495–497. 3 indexed citations
19.
Barr, Ian, Sylvia Miescher, V von Fliedner, et al.. (1989). In vivo localization of a bispecific antibody which targets human t lymphocytes to lyse human colon cancer cells. International Journal of Cancer. 43(3). 501–507. 24 indexed citations
20.
Audette, Marie, Franz Buchegger, Magali Schreyer, & Jean‐Pierre Mach. (1987). Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes. Molecular Immunology. 24(11). 1177–1186. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026